OpenFilings

ORAMED PHARMACEUTICALS INC.

Form10-K

Report Period2024-12-31

Date Filed2025-03-27

Time Filed17:00:24

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

ANNUAL REPORT
FIFTH AMENDED AND RESTATED BY-LAWS, ADOPTED EFFECTIVE MARCH 27, 2025
FIFTH AMENDED AND RESTATED BY-LAWS, ADOPTED EFFECTIVE MARCH 27, 2025 (MARKED COP
DESCRIPTION OF SECURITIES
AMENDMENT, DATED NOVEMBER 7, 2024, TO EMPLOYMENT AGREEMENT BY AND BETWEEN ORAMED
AMENDMENT, DATED NOVEMBER 7, 2024, TO EMPLOYMENT AGREEMENT BY AND BETWEEN ORAMED
AMENDMENT, DATED NOVEMBER 7, 2024, TO CONSULTING AGREEMENTS BY AND BETWEEN ORAME
ORAMED PHARMACEUTICALS INC. INSIDER TRADING POLICY
SUBSIDIARIES
CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER
CERTIFICATION
CERTIFICATION
CERTIFICATION
CERTIFICATION
Filing on SEC Edgar